In a mixed lineage leukemia mouse model, mice treated with LSD1 inhibitor showed substantial decreases in leukemic cell proliferation, but the treated mice presented with greater levels of anemia and thrombocytopenia compared to vehicle-treated control mice (Harris et al., 2012). The gene discussed is KDM1A; the disease is anemia (phenotype).